Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124730913 | 12473091 | 3 | F | 201506 | 20160708 | 20160616 | 20160714 | EXP | PHHY2016BR082188 | NOVARTIS | 85.23 | YR | F | Y | 60.00000 | KG | 20160715 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124730913 | 12473091 | 1 | PS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 1 DF (5 MG/ 100 ML), Q12MO | 21817 | 1 | DF | SOLUTION FOR INJECTION | |||||||
| 124730913 | 12473091 | 2 | SS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | UNK | 21817 | SOLUTION FOR INJECTION | |||||||||
| 124730913 | 12473091 | 3 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 15 MG, QD | 0 | 15 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||
| 124730913 | 12473091 | 4 | C | RIVOTRIL | CLONAZEPAM | 1 | Oral | 1 DF, QD (APPROXIMATLEY 10 YEARS) | 0 | 1 | DF | TABLET | QD | ||||||
| 124730913 | 12473091 | 5 | C | SIFROL | PRAMIPEXOLE | 1 | Oral | 1 DF, QD (7 YEARS AGO) | 0 | 1 | DF | TABLET | QD | ||||||
| 124730913 | 12473091 | 6 | C | PROLOPA | BENSERAZIDELEVODOPA | 1 | Oral | 1 DF(100+25 MG), TID (7 YEARS AGO) | 0 | 1 | DF | TID | |||||||
| 124730913 | 12473091 | 7 | C | QUETIAPINE. | QUETIAPINE | 1 | Oral | 1 DF, QD (2 YEARS AGO) | 0 | 1 | DF | TABLET | QD | ||||||
| 124730913 | 12473091 | 8 | C | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 1 DF, QD (2 YEARS AGO) | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124730913 | 12473091 | 1 | Osteoporosis |
| 124730913 | 12473091 | 2 | Spinal fracture |
| 124730913 | 12473091 | 3 | Dementia Alzheimer's type |
| 124730913 | 12473091 | 4 | Sleep disorder |
| 124730913 | 12473091 | 5 | Parkinson's disease |
| 124730913 | 12473091 | 6 | Parkinson's disease |
| 124730913 | 12473091 | 7 | Sleep disorder |
| 124730913 | 12473091 | 8 | Antidepressant therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124730913 | 12473091 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124730913 | 12473091 | Crying | |
| 124730913 | 12473091 | Fall | |
| 124730913 | 12473091 | Femur fracture | |
| 124730913 | 12473091 | General physical health deterioration | |
| 124730913 | 12473091 | Spinal fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124730913 | 12473091 | 2 | 201503 | 0 |